Low dose dinaciclib enhances doxorubicin‑induced senescence in myeloma RPMI8226 cells by transformation of the p21 and p16 pathwaysHailong Tang, Guangxun Gao|Oncology Letters|2018Cited by 12
Chromosome 1q21 gain is an adverse prognostic factor for newly diagnosed multiple myeloma patients treated with bortezomib-based regimensXiao Liu, Guangxun Gao, Yuping Chu et al.|Frontiers in Oncology|2022Cited by 10